nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—ABCB1—kidney cancer	0.25	1	CbGaD
Fesoterodine—ABCB1—Temsirolimus—kidney cancer	0.0535	0.1	CbGbCtD
Fesoterodine—CYP2D6—Temsirolimus—kidney cancer	0.0504	0.0942	CbGbCtD
Fesoterodine—CYP3A4—Everolimus—kidney cancer	0.0475	0.0887	CbGbCtD
Fesoterodine—CYP3A4—Temsirolimus—kidney cancer	0.0321	0.0599	CbGbCtD
Fesoterodine—ABCB1—Pazopanib—kidney cancer	0.0281	0.0525	CbGbCtD
Fesoterodine—CYP2D6—Pazopanib—kidney cancer	0.0265	0.0495	CbGbCtD
Fesoterodine—ABCB1—Dactinomycin—kidney cancer	0.0257	0.048	CbGbCtD
Fesoterodine—ABCB1—Gemcitabine—kidney cancer	0.0203	0.038	CbGbCtD
Fesoterodine—ABCB1—Erlotinib—kidney cancer	0.0201	0.0375	CbGbCtD
Fesoterodine—CYP2D6—Erlotinib—kidney cancer	0.0189	0.0353	CbGbCtD
Fesoterodine—ABCB1—Paclitaxel—kidney cancer	0.0184	0.0343	CbGbCtD
Fesoterodine—CYP3A4—Pazopanib—kidney cancer	0.0168	0.0315	CbGbCtD
Fesoterodine—ABCB1—Sorafenib—kidney cancer	0.0163	0.0305	CbGbCtD
Fesoterodine—ABCB1—Vinblastine—kidney cancer	0.0161	0.0301	CbGbCtD
Fesoterodine—ABCB1—Vincristine—kidney cancer	0.0158	0.0296	CbGbCtD
Fesoterodine—CYP2D6—Sorafenib—kidney cancer	0.0154	0.0287	CbGbCtD
Fesoterodine—CYP2D6—Vinblastine—kidney cancer	0.0152	0.0284	CbGbCtD
Fesoterodine—ABCB1—Sunitinib—kidney cancer	0.0132	0.0247	CbGbCtD
Fesoterodine—CYP3A4—Erlotinib—kidney cancer	0.012	0.0225	CbGbCtD
Fesoterodine—CYP3A4—Paclitaxel—kidney cancer	0.011	0.0206	CbGbCtD
Fesoterodine—ABCB1—Doxorubicin—kidney cancer	0.0099	0.0185	CbGbCtD
Fesoterodine—CYP3A4—Sorafenib—kidney cancer	0.00978	0.0183	CbGbCtD
Fesoterodine—CYP3A4—Vinblastine—kidney cancer	0.00965	0.018	CbGbCtD
Fesoterodine—CYP3A4—Vincristine—kidney cancer	0.00949	0.0177	CbGbCtD
Fesoterodine—CYP2D6—Doxorubicin—kidney cancer	0.00933	0.0174	CbGbCtD
Fesoterodine—CHRM3—ureter—kidney cancer	0.00869	0.546	CbGeAlD
Fesoterodine—CYP3A4—Sunitinib—kidney cancer	0.00792	0.0148	CbGbCtD
Fesoterodine—CYP3A4—Doxorubicin—kidney cancer	0.00593	0.0111	CbGbCtD
Fesoterodine—CYP3A4—urine—kidney cancer	0.00155	0.0974	CbGeAlD
Fesoterodine—CYP2D6—urine—kidney cancer	0.00153	0.0959	CbGeAlD
Fesoterodine—CHRM3—renal system—kidney cancer	0.000691	0.0434	CbGeAlD
Fesoterodine—CHRM3—kidney—kidney cancer	0.000668	0.0419	CbGeAlD
Fesoterodine—CYP3A4—renal system—kidney cancer	0.00038	0.0238	CbGeAlD
Fesoterodine—CYP2D6—renal system—kidney cancer	0.000373	0.0235	CbGeAlD
Fesoterodine—CYP3A4—kidney—kidney cancer	0.000367	0.023	CbGeAlD
Fesoterodine—CYP2D6—kidney—kidney cancer	0.000361	0.0227	CbGeAlD
Fesoterodine—Abdominal pain—Vinblastine—kidney cancer	0.000308	0.00163	CcSEcCtD
Fesoterodine—Headache—Pazopanib—kidney cancer	0.000308	0.00163	CcSEcCtD
Fesoterodine—Abdominal pain—Everolimus—kidney cancer	0.000307	0.00162	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Erlotinib—kidney cancer	0.000307	0.00162	CcSEcCtD
Fesoterodine—Angina pectoris—Capecitabine—kidney cancer	0.000307	0.00162	CcSEcCtD
Fesoterodine—Infection—Dactinomycin—kidney cancer	0.000305	0.00161	CcSEcCtD
Fesoterodine—Urinary tract disorder—Paclitaxel—kidney cancer	0.000303	0.0016	CcSEcCtD
Fesoterodine—Oedema peripheral—Paclitaxel—kidney cancer	0.000302	0.0016	CcSEcCtD
Fesoterodine—Vertigo—Vincristine—kidney cancer	0.000302	0.0016	CcSEcCtD
Fesoterodine—Abdominal discomfort—Capecitabine—kidney cancer	0.000302	0.0016	CcSEcCtD
Fesoterodine—Urethral disorder—Paclitaxel—kidney cancer	0.000301	0.00159	CcSEcCtD
Fesoterodine—Dry eye—Doxorubicin—kidney cancer	0.000299	0.00158	CcSEcCtD
Fesoterodine—Dyspepsia—Sorafenib—kidney cancer	0.000297	0.00157	CcSEcCtD
Fesoterodine—Abdominal pain—Erlotinib—kidney cancer	0.000297	0.00157	CcSEcCtD
Fesoterodine—ABCB1—nephron tubule—kidney cancer	0.000296	0.0186	CbGeAlD
Fesoterodine—Dysuria—Capecitabine—kidney cancer	0.000294	0.00156	CcSEcCtD
Fesoterodine—Insomnia—Sunitinib—kidney cancer	0.000294	0.00155	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000293	0.00155	CcSEcCtD
Fesoterodine—Nausea—Pazopanib—kidney cancer	0.000292	0.00155	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000291	0.00154	CcSEcCtD
Fesoterodine—Fatigue—Sorafenib—kidney cancer	0.000291	0.00154	CcSEcCtD
Fesoterodine—Constipation—Sorafenib—kidney cancer	0.000289	0.00153	CcSEcCtD
Fesoterodine—Hypersensitivity—Vinblastine—kidney cancer	0.000288	0.00152	CcSEcCtD
Fesoterodine—Eye disorder—Paclitaxel—kidney cancer	0.000287	0.00152	CcSEcCtD
Fesoterodine—Hypersensitivity—Everolimus—kidney cancer	0.000286	0.00151	CcSEcCtD
Fesoterodine—Dyspepsia—Sunitinib—kidney cancer	0.000286	0.00151	CcSEcCtD
Fesoterodine—Cardiac disorder—Paclitaxel—kidney cancer	0.000285	0.00151	CcSEcCtD
Fesoterodine—Infestation—Capecitabine—kidney cancer	0.000281	0.00148	CcSEcCtD
Fesoterodine—Infestation NOS—Capecitabine—kidney cancer	0.000281	0.00148	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00028	0.00148	CcSEcCtD
Fesoterodine—Asthenia—Vinblastine—kidney cancer	0.00028	0.00148	CcSEcCtD
Fesoterodine—Fatigue—Sunitinib—kidney cancer	0.00028	0.00148	CcSEcCtD
Fesoterodine—Asthenia—Everolimus—kidney cancer	0.000279	0.00147	CcSEcCtD
Fesoterodine—Cough—Gemcitabine—kidney cancer	0.000279	0.00147	CcSEcCtD
Fesoterodine—Constipation—Sunitinib—kidney cancer	0.000278	0.00147	CcSEcCtD
Fesoterodine—Mediastinal disorder—Paclitaxel—kidney cancer	0.000277	0.00146	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000276	0.00146	CcSEcCtD
Fesoterodine—Pruritus—Everolimus—kidney cancer	0.000275	0.00145	CcSEcCtD
Fesoterodine—Infection—Vincristine—kidney cancer	0.000273	0.00144	CcSEcCtD
Fesoterodine—Urinary tract infection—Capecitabine—kidney cancer	0.000273	0.00144	CcSEcCtD
Fesoterodine—Chest pain—Gemcitabine—kidney cancer	0.000272	0.00144	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00027	0.00143	CcSEcCtD
Fesoterodine—Nervous system disorder—Vincristine—kidney cancer	0.000269	0.00142	CcSEcCtD
Fesoterodine—Asthenia—Erlotinib—kidney cancer	0.000269	0.00142	CcSEcCtD
Fesoterodine—Mental disorder—Paclitaxel—kidney cancer	0.000269	0.00142	CcSEcCtD
Fesoterodine—ABCB1—renal system—kidney cancer	0.000269	0.0169	CbGeAlD
Fesoterodine—Urticaria—Sorafenib—kidney cancer	0.000268	0.00142	CcSEcCtD
Fesoterodine—Diarrhoea—Vinblastine—kidney cancer	0.000267	0.00141	CcSEcCtD
Fesoterodine—Abdominal pain—Sorafenib—kidney cancer	0.000267	0.00141	CcSEcCtD
Fesoterodine—Diarrhoea—Everolimus—kidney cancer	0.000266	0.00141	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000266	0.0014	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Capecitabine—kidney cancer	0.000265	0.0014	CcSEcCtD
Fesoterodine—Pruritus—Erlotinib—kidney cancer	0.000265	0.0014	CcSEcCtD
Fesoterodine—Fatigue—Dactinomycin—kidney cancer	0.000265	0.0014	CcSEcCtD
Fesoterodine—Flatulence—Paclitaxel—kidney cancer	0.000263	0.00139	CcSEcCtD
Fesoterodine—Dysgeusia—Paclitaxel—kidney cancer	0.000262	0.00138	CcSEcCtD
Fesoterodine—ABCB1—kidney—kidney cancer	0.00026	0.0163	CbGeAlD
Fesoterodine—Infection—Gemcitabine—kidney cancer	0.000259	0.00137	CcSEcCtD
Fesoterodine—Back pain—Paclitaxel—kidney cancer	0.000259	0.00137	CcSEcCtD
Fesoterodine—Dizziness—Vinblastine—kidney cancer	0.000258	0.00136	CcSEcCtD
Fesoterodine—Dizziness—Everolimus—kidney cancer	0.000257	0.00136	CcSEcCtD
Fesoterodine—Abdominal pain—Sunitinib—kidney cancer	0.000257	0.00136	CcSEcCtD
Fesoterodine—Diarrhoea—Erlotinib—kidney cancer	0.000257	0.00136	CcSEcCtD
Fesoterodine—Nervous system disorder—Gemcitabine—kidney cancer	0.000256	0.00135	CcSEcCtD
Fesoterodine—Feeling abnormal—Dactinomycin—kidney cancer	0.000253	0.00134	CcSEcCtD
Fesoterodine—Skin disorder—Gemcitabine—kidney cancer	0.000253	0.00134	CcSEcCtD
Fesoterodine—ABCB1—cortex of kidney—kidney cancer	0.000253	0.0159	CbGeAlD
Fesoterodine—Vision blurred—Paclitaxel—kidney cancer	0.000252	0.00133	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000251	0.00133	CcSEcCtD
Fesoterodine—Urinary tract disorder—Capecitabine—kidney cancer	0.000249	0.00132	CcSEcCtD
Fesoterodine—Hypersensitivity—Sorafenib—kidney cancer	0.000249	0.00131	CcSEcCtD
Fesoterodine—Insomnia—Vincristine—kidney cancer	0.000248	0.00131	CcSEcCtD
Fesoterodine—Oedema peripheral—Capecitabine—kidney cancer	0.000248	0.00131	CcSEcCtD
Fesoterodine—Dizziness—Erlotinib—kidney cancer	0.000248	0.00131	CcSEcCtD
Fesoterodine—Urethral disorder—Capecitabine—kidney cancer	0.000247	0.00131	CcSEcCtD
Fesoterodine—Rash—Everolimus—kidney cancer	0.000245	0.0013	CcSEcCtD
Fesoterodine—Dermatitis—Everolimus—kidney cancer	0.000245	0.00129	CcSEcCtD
Fesoterodine—Headache—Vinblastine—kidney cancer	0.000244	0.00129	CcSEcCtD
Fesoterodine—Angioedema—Paclitaxel—kidney cancer	0.000244	0.00129	CcSEcCtD
Fesoterodine—Headache—Everolimus—kidney cancer	0.000244	0.00129	CcSEcCtD
Fesoterodine—Abdominal pain—Dactinomycin—kidney cancer	0.000243	0.00128	CcSEcCtD
Fesoterodine—Asthenia—Sorafenib—kidney cancer	0.000242	0.00128	CcSEcCtD
Fesoterodine—ABCB1—gonad—kidney cancer	0.000241	0.0151	CbGeAlD
Fesoterodine—Vertigo—Paclitaxel—kidney cancer	0.00024	0.00127	CcSEcCtD
Fesoterodine—Hypersensitivity—Sunitinib—kidney cancer	0.000239	0.00126	CcSEcCtD
Fesoterodine—Pruritus—Sorafenib—kidney cancer	0.000239	0.00126	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000237	0.00125	CcSEcCtD
Fesoterodine—Fatigue—Vincristine—kidney cancer	0.000237	0.00125	CcSEcCtD
Fesoterodine—Rash—Erlotinib—kidney cancer	0.000236	0.00125	CcSEcCtD
Fesoterodine—Dermatitis—Erlotinib—kidney cancer	0.000236	0.00125	CcSEcCtD
Fesoterodine—Palpitations—Paclitaxel—kidney cancer	0.000236	0.00125	CcSEcCtD
Fesoterodine—Insomnia—Gemcitabine—kidney cancer	0.000236	0.00125	CcSEcCtD
Fesoterodine—Eye disorder—Capecitabine—kidney cancer	0.000235	0.00124	CcSEcCtD
Fesoterodine—Headache—Erlotinib—kidney cancer	0.000235	0.00124	CcSEcCtD
Fesoterodine—Constipation—Vincristine—kidney cancer	0.000235	0.00124	CcSEcCtD
Fesoterodine—Cardiac disorder—Capecitabine—kidney cancer	0.000234	0.00124	CcSEcCtD
Fesoterodine—Cough—Paclitaxel—kidney cancer	0.000233	0.00123	CcSEcCtD
Fesoterodine—Asthenia—Sunitinib—kidney cancer	0.000233	0.00123	CcSEcCtD
Fesoterodine—Nausea—Vinblastine—kidney cancer	0.000232	0.00123	CcSEcCtD
Fesoterodine—Somnolence—Gemcitabine—kidney cancer	0.000232	0.00122	CcSEcCtD
Fesoterodine—Nausea—Everolimus—kidney cancer	0.000231	0.00122	CcSEcCtD
Fesoterodine—Diarrhoea—Sorafenib—kidney cancer	0.000231	0.00122	CcSEcCtD
Fesoterodine—Pruritus—Sunitinib—kidney cancer	0.00023	0.00121	CcSEcCtD
Fesoterodine—Chest pain—Paclitaxel—kidney cancer	0.000228	0.0012	CcSEcCtD
Fesoterodine—Mediastinal disorder—Capecitabine—kidney cancer	0.000227	0.0012	CcSEcCtD
Fesoterodine—Face oedema—Doxorubicin—kidney cancer	0.000227	0.0012	CcSEcCtD
Fesoterodine—Hypersensitivity—Dactinomycin—kidney cancer	0.000226	0.0012	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000226	0.00119	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000225	0.00119	CcSEcCtD
Fesoterodine—Fatigue—Gemcitabine—kidney cancer	0.000225	0.00119	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Vincristine—kidney cancer	0.000225	0.00119	CcSEcCtD
Fesoterodine—Dizziness—Sorafenib—kidney cancer	0.000223	0.00118	CcSEcCtD
Fesoterodine—Constipation—Gemcitabine—kidney cancer	0.000223	0.00118	CcSEcCtD
Fesoterodine—Nausea—Erlotinib—kidney cancer	0.000223	0.00118	CcSEcCtD
Fesoterodine—Dry mouth—Paclitaxel—kidney cancer	0.000223	0.00118	CcSEcCtD
Fesoterodine—Diarrhoea—Sunitinib—kidney cancer	0.000222	0.00117	CcSEcCtD
Fesoterodine—Mental disorder—Capecitabine—kidney cancer	0.000221	0.00117	CcSEcCtD
Fesoterodine—Asthenia—Dactinomycin—kidney cancer	0.000221	0.00117	CcSEcCtD
Fesoterodine—Confusional state—Paclitaxel—kidney cancer	0.00022	0.00116	CcSEcCtD
Fesoterodine—Abdominal pain—Vincristine—kidney cancer	0.000217	0.00115	CcSEcCtD
Fesoterodine—Infection—Paclitaxel—kidney cancer	0.000217	0.00115	CcSEcCtD
Fesoterodine—Flatulence—Capecitabine—kidney cancer	0.000216	0.00114	CcSEcCtD
Fesoterodine—Dry skin—Doxorubicin—kidney cancer	0.000215	0.00114	CcSEcCtD
Fesoterodine—Dysgeusia—Capecitabine—kidney cancer	0.000215	0.00114	CcSEcCtD
Fesoterodine—Dizziness—Sunitinib—kidney cancer	0.000215	0.00114	CcSEcCtD
Fesoterodine—Feeling abnormal—Gemcitabine—kidney cancer	0.000215	0.00114	CcSEcCtD
Fesoterodine—Abdominal pain upper—Doxorubicin—kidney cancer	0.000214	0.00113	CcSEcCtD
Fesoterodine—Nervous system disorder—Paclitaxel—kidney cancer	0.000214	0.00113	CcSEcCtD
Fesoterodine—Tachycardia—Paclitaxel—kidney cancer	0.000213	0.00113	CcSEcCtD
Fesoterodine—Rash—Sorafenib—kidney cancer	0.000213	0.00112	CcSEcCtD
Fesoterodine—Dermatitis—Sorafenib—kidney cancer	0.000213	0.00112	CcSEcCtD
Fesoterodine—Back pain—Capecitabine—kidney cancer	0.000212	0.00112	CcSEcCtD
Fesoterodine—Skin disorder—Paclitaxel—kidney cancer	0.000212	0.00112	CcSEcCtD
Fesoterodine—Headache—Sorafenib—kidney cancer	0.000211	0.00112	CcSEcCtD
Fesoterodine—Diarrhoea—Dactinomycin—kidney cancer	0.00021	0.00111	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000207	0.00109	CcSEcCtD
Fesoterodine—Vision blurred—Capecitabine—kidney cancer	0.000207	0.00109	CcSEcCtD
Fesoterodine—Rash—Sunitinib—kidney cancer	0.000205	0.00108	CcSEcCtD
Fesoterodine—Dermatitis—Sunitinib—kidney cancer	0.000205	0.00108	CcSEcCtD
Fesoterodine—Headache—Sunitinib—kidney cancer	0.000203	0.00108	CcSEcCtD
Fesoterodine—Hypersensitivity—Vincristine—kidney cancer	0.000202	0.00107	CcSEcCtD
Fesoterodine—Nausea—Sorafenib—kidney cancer	0.0002	0.00106	CcSEcCtD
Fesoterodine—Angina pectoris—Doxorubicin—kidney cancer	0.000198	0.00105	CcSEcCtD
Fesoterodine—Insomnia—Paclitaxel—kidney cancer	0.000197	0.00104	CcSEcCtD
Fesoterodine—Vertigo—Capecitabine—kidney cancer	0.000197	0.00104	CcSEcCtD
Fesoterodine—Asthenia—Vincristine—kidney cancer	0.000197	0.00104	CcSEcCtD
Fesoterodine—Somnolence—Paclitaxel—kidney cancer	0.000194	0.00103	CcSEcCtD
Fesoterodine—Palpitations—Capecitabine—kidney cancer	0.000194	0.00102	CcSEcCtD
Fesoterodine—Rash—Dactinomycin—kidney cancer	0.000194	0.00102	CcSEcCtD
Fesoterodine—Nausea—Sunitinib—kidney cancer	0.000193	0.00102	CcSEcCtD
Fesoterodine—Dyspepsia—Paclitaxel—kidney cancer	0.000192	0.00102	CcSEcCtD
Fesoterodine—Cough—Capecitabine—kidney cancer	0.000191	0.00101	CcSEcCtD
Fesoterodine—Dysuria—Doxorubicin—kidney cancer	0.00019	0.001	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000189	0.000997	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000188	0.000996	CcSEcCtD
Fesoterodine—Fatigue—Paclitaxel—kidney cancer	0.000188	0.000994	CcSEcCtD
Fesoterodine—Diarrhoea—Vincristine—kidney cancer	0.000188	0.000993	CcSEcCtD
Fesoterodine—Asthenia—Gemcitabine—kidney cancer	0.000187	0.000988	CcSEcCtD
Fesoterodine—Chest pain—Capecitabine—kidney cancer	0.000187	0.000987	CcSEcCtD
Fesoterodine—Constipation—Paclitaxel—kidney cancer	0.000187	0.000986	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000185	0.00098	CcSEcCtD
Fesoterodine—Pruritus—Gemcitabine—kidney cancer	0.000184	0.000975	CcSEcCtD
Fesoterodine—Dry mouth—Capecitabine—kidney cancer	0.000183	0.000966	CcSEcCtD
Fesoterodine—Nausea—Dactinomycin—kidney cancer	0.000183	0.000965	CcSEcCtD
Fesoterodine—Dizziness—Vincristine—kidney cancer	0.000182	0.00096	CcSEcCtD
Fesoterodine—Infestation NOS—Doxorubicin—kidney cancer	0.000181	0.000957	CcSEcCtD
Fesoterodine—Infestation—Doxorubicin—kidney cancer	0.000181	0.000957	CcSEcCtD
Fesoterodine—Confusional state—Capecitabine—kidney cancer	0.00018	0.000954	CcSEcCtD
Fesoterodine—Feeling abnormal—Paclitaxel—kidney cancer	0.00018	0.00095	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000178	0.000943	CcSEcCtD
Fesoterodine—Diarrhoea—Gemcitabine—kidney cancer	0.000178	0.000942	CcSEcCtD
Fesoterodine—Infection—Capecitabine—kidney cancer	0.000178	0.00094	CcSEcCtD
Fesoterodine—Urinary tract infection—Doxorubicin—kidney cancer	0.000176	0.00093	CcSEcCtD
Fesoterodine—Nervous system disorder—Capecitabine—kidney cancer	0.000176	0.000928	CcSEcCtD
Fesoterodine—Tachycardia—Capecitabine—kidney cancer	0.000175	0.000924	CcSEcCtD
Fesoterodine—Skin disorder—Capecitabine—kidney cancer	0.000174	0.000919	CcSEcCtD
Fesoterodine—Urticaria—Paclitaxel—kidney cancer	0.000173	0.000916	CcSEcCtD
Fesoterodine—Rash—Vincristine—kidney cancer	0.000173	0.000916	CcSEcCtD
Fesoterodine—Dermatitis—Vincristine—kidney cancer	0.000173	0.000915	CcSEcCtD
Fesoterodine—Abdominal pain—Paclitaxel—kidney cancer	0.000172	0.000912	CcSEcCtD
Fesoterodine—Headache—Vincristine—kidney cancer	0.000172	0.00091	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000171	0.000905	CcSEcCtD
Fesoterodine—Rash—Gemcitabine—kidney cancer	0.000164	0.000869	CcSEcCtD
Fesoterodine—Dermatitis—Gemcitabine—kidney cancer	0.000164	0.000868	CcSEcCtD
Fesoterodine—Headache—Gemcitabine—kidney cancer	0.000163	0.000863	CcSEcCtD
Fesoterodine—Nausea—Vincristine—kidney cancer	0.000163	0.000862	CcSEcCtD
Fesoterodine—Insomnia—Capecitabine—kidney cancer	0.000162	0.000856	CcSEcCtD
Fesoterodine—Hypersensitivity—Paclitaxel—kidney cancer	0.000161	0.00085	CcSEcCtD
Fesoterodine—Urinary tract disorder—Doxorubicin—kidney cancer	0.00016	0.000848	CcSEcCtD
Fesoterodine—Oedema peripheral—Doxorubicin—kidney cancer	0.00016	0.000846	CcSEcCtD
Fesoterodine—Urethral disorder—Doxorubicin—kidney cancer	0.000159	0.000842	CcSEcCtD
Fesoterodine—Dyspepsia—Capecitabine—kidney cancer	0.000158	0.000833	CcSEcCtD
Fesoterodine—Asthenia—Paclitaxel—kidney cancer	0.000157	0.000827	CcSEcCtD
Fesoterodine—Nausea—Gemcitabine—kidney cancer	0.000155	0.000818	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000155	0.000817	CcSEcCtD
Fesoterodine—Fatigue—Capecitabine—kidney cancer	0.000154	0.000816	CcSEcCtD
Fesoterodine—Pruritus—Paclitaxel—kidney cancer	0.000154	0.000816	CcSEcCtD
Fesoterodine—Constipation—Capecitabine—kidney cancer	0.000153	0.000809	CcSEcCtD
Fesoterodine—Eye disorder—Doxorubicin—kidney cancer	0.000152	0.000802	CcSEcCtD
Fesoterodine—Cardiac disorder—Doxorubicin—kidney cancer	0.000151	0.000797	CcSEcCtD
Fesoterodine—Diarrhoea—Paclitaxel—kidney cancer	0.000149	0.000789	CcSEcCtD
Fesoterodine—Feeling abnormal—Capecitabine—kidney cancer	0.000148	0.00078	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000146	0.000774	CcSEcCtD
Fesoterodine—Mediastinal disorder—Doxorubicin—kidney cancer	0.000146	0.000774	CcSEcCtD
Fesoterodine—Dizziness—Paclitaxel—kidney cancer	0.000144	0.000763	CcSEcCtD
Fesoterodine—Mental disorder—Doxorubicin—kidney cancer	0.000142	0.000752	CcSEcCtD
Fesoterodine—Urticaria—Capecitabine—kidney cancer	0.000142	0.000752	CcSEcCtD
Fesoterodine—Abdominal pain—Capecitabine—kidney cancer	0.000142	0.000748	CcSEcCtD
Fesoterodine—Flatulence—Doxorubicin—kidney cancer	0.000139	0.000737	CcSEcCtD
Fesoterodine—Dysgeusia—Doxorubicin—kidney cancer	0.000138	0.000732	CcSEcCtD
Fesoterodine—Rash—Paclitaxel—kidney cancer	0.000138	0.000727	CcSEcCtD
Fesoterodine—Dermatitis—Paclitaxel—kidney cancer	0.000137	0.000726	CcSEcCtD
Fesoterodine—Back pain—Doxorubicin—kidney cancer	0.000137	0.000723	CcSEcCtD
Fesoterodine—Headache—Paclitaxel—kidney cancer	0.000137	0.000722	CcSEcCtD
Fesoterodine—Vision blurred—Doxorubicin—kidney cancer	0.000133	0.000704	CcSEcCtD
Fesoterodine—Hypersensitivity—Capecitabine—kidney cancer	0.000132	0.000697	CcSEcCtD
Fesoterodine—Nausea—Paclitaxel—kidney cancer	0.00013	0.000685	CcSEcCtD
Fesoterodine—Asthenia—Capecitabine—kidney cancer	0.000128	0.000679	CcSEcCtD
Fesoterodine—Vertigo—Doxorubicin—kidney cancer	0.000127	0.000672	CcSEcCtD
Fesoterodine—Pruritus—Capecitabine—kidney cancer	0.000127	0.00067	CcSEcCtD
Fesoterodine—Palpitations—Doxorubicin—kidney cancer	0.000125	0.000661	CcSEcCtD
Fesoterodine—Cough—Doxorubicin—kidney cancer	0.000123	0.000652	CcSEcCtD
Fesoterodine—Diarrhoea—Capecitabine—kidney cancer	0.000122	0.000648	CcSEcCtD
Fesoterodine—Chest pain—Doxorubicin—kidney cancer	0.00012	0.000636	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.00012	0.000632	CcSEcCtD
Fesoterodine—Dizziness—Capecitabine—kidney cancer	0.000118	0.000626	CcSEcCtD
Fesoterodine—Dry mouth—Doxorubicin—kidney cancer	0.000118	0.000622	CcSEcCtD
Fesoterodine—Confusional state—Doxorubicin—kidney cancer	0.000116	0.000615	CcSEcCtD
Fesoterodine—Infection—Doxorubicin—kidney cancer	0.000115	0.000606	CcSEcCtD
Fesoterodine—Nervous system disorder—Doxorubicin—kidney cancer	0.000113	0.000598	CcSEcCtD
Fesoterodine—Rash—Capecitabine—kidney cancer	0.000113	0.000597	CcSEcCtD
Fesoterodine—Dermatitis—Capecitabine—kidney cancer	0.000113	0.000596	CcSEcCtD
Fesoterodine—Tachycardia—Doxorubicin—kidney cancer	0.000113	0.000595	CcSEcCtD
Fesoterodine—Headache—Capecitabine—kidney cancer	0.000112	0.000593	CcSEcCtD
Fesoterodine—Skin disorder—Doxorubicin—kidney cancer	0.000112	0.000593	CcSEcCtD
Fesoterodine—Nausea—Capecitabine—kidney cancer	0.000106	0.000562	CcSEcCtD
Fesoterodine—Insomnia—Doxorubicin—kidney cancer	0.000104	0.000552	CcSEcCtD
Fesoterodine—Somnolence—Doxorubicin—kidney cancer	0.000103	0.000542	CcSEcCtD
Fesoterodine—Dyspepsia—Doxorubicin—kidney cancer	0.000102	0.000537	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.96e-05	0.000527	CcSEcCtD
Fesoterodine—Fatigue—Doxorubicin—kidney cancer	9.95e-05	0.000526	CcSEcCtD
Fesoterodine—Constipation—Doxorubicin—kidney cancer	9.87e-05	0.000522	CcSEcCtD
Fesoterodine—Feeling abnormal—Doxorubicin—kidney cancer	9.51e-05	0.000503	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Doxorubicin—kidney cancer	9.44e-05	0.000499	CcSEcCtD
Fesoterodine—Urticaria—Doxorubicin—kidney cancer	9.17e-05	0.000485	CcSEcCtD
Fesoterodine—Abdominal pain—Doxorubicin—kidney cancer	9.12e-05	0.000482	CcSEcCtD
Fesoterodine—Hypersensitivity—Doxorubicin—kidney cancer	8.5e-05	0.000449	CcSEcCtD
Fesoterodine—Asthenia—Doxorubicin—kidney cancer	8.28e-05	0.000438	CcSEcCtD
Fesoterodine—Pruritus—Doxorubicin—kidney cancer	8.16e-05	0.000432	CcSEcCtD
Fesoterodine—Diarrhoea—Doxorubicin—kidney cancer	7.9e-05	0.000417	CcSEcCtD
Fesoterodine—Dizziness—Doxorubicin—kidney cancer	7.63e-05	0.000403	CcSEcCtD
Fesoterodine—Rash—Doxorubicin—kidney cancer	7.28e-05	0.000385	CcSEcCtD
Fesoterodine—Dermatitis—Doxorubicin—kidney cancer	7.27e-05	0.000384	CcSEcCtD
Fesoterodine—Headache—Doxorubicin—kidney cancer	7.23e-05	0.000382	CcSEcCtD
Fesoterodine—Nausea—Doxorubicin—kidney cancer	6.85e-05	0.000362	CcSEcCtD
Fesoterodine—CHRM5—GPCR downstream signaling—IL2—kidney cancer	4.2e-06	0.000435	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FLT1—kidney cancer	4.19e-06	0.000434	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GPC3—kidney cancer	4.18e-06	0.000433	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.15e-06	0.000429	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CA2—kidney cancer	4.07e-06	0.000421	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CRABP1—kidney cancer	4.01e-06	0.000415	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—POMC—kidney cancer	4e-06	0.000415	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—POMC—kidney cancer	3.99e-06	0.000413	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL2—kidney cancer	3.99e-06	0.000413	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALAD—kidney cancer	3.97e-06	0.000411	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ITPR2—kidney cancer	3.96e-06	0.00041	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—POMC—kidney cancer	3.95e-06	0.000409	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GSTP1—kidney cancer	3.94e-06	0.000408	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—JUNB—kidney cancer	3.94e-06	0.000408	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PAK1—kidney cancer	3.94e-06	0.000408	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PAK1—kidney cancer	3.92e-06	0.000406	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—JUNB—kidney cancer	3.92e-06	0.000406	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—JUNB—kidney cancer	3.89e-06	0.000402	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PAK1—kidney cancer	3.89e-06	0.000402	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.87e-06	0.000401	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL2—kidney cancer	3.82e-06	0.000395	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HIF1A—kidney cancer	3.8e-06	0.000393	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TSC2—kidney cancer	3.79e-06	0.000392	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.78e-06	0.000392	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ABCB1—kidney cancer	3.73e-06	0.000386	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ITPR2—kidney cancer	3.73e-06	0.000386	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HIF1A—kidney cancer	3.64e-06	0.000377	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—POMC—kidney cancer	3.64e-06	0.000376	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—KDR—kidney cancer	3.63e-06	0.000376	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TSC2—kidney cancer	3.63e-06	0.000376	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PGK1—kidney cancer	3.63e-06	0.000376	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.63e-06	0.000376	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—POMC—kidney cancer	3.62e-06	0.000375	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GSTM1—kidney cancer	3.62e-06	0.000375	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTT1—kidney cancer	3.61e-06	0.000374	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ACHE—kidney cancer	3.61e-06	0.000374	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—POMC—kidney cancer	3.59e-06	0.000372	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—LDHB—kidney cancer	3.56e-06	0.000368	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—KDR—kidney cancer	3.48e-06	0.00036	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP1A1—kidney cancer	3.43e-06	0.000356	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—SCARB1—kidney cancer	3.42e-06	0.000354	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTT1—kidney cancer	3.4e-06	0.000352	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ACHE—kidney cancer	3.4e-06	0.000352	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS1—kidney cancer	3.38e-06	0.00035	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—APC—kidney cancer	3.35e-06	0.000346	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—KIT—kidney cancer	3.35e-06	0.000346	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PSMD7—kidney cancer	3.32e-06	0.000343	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—SCARB1—kidney cancer	3.22e-06	0.000333	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF2—kidney cancer	3.22e-06	0.000333	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF2—kidney cancer	3.21e-06	0.000332	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—MAPK3—kidney cancer	3.2e-06	0.000332	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—APC—kidney cancer	3.2e-06	0.000332	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—KIT—kidney cancer	3.2e-06	0.000332	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CDKN2B—kidney cancer	3.2e-06	0.000332	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CDKN2B—kidney cancer	3.19e-06	0.000331	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS1—kidney cancer	3.19e-06	0.00033	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—POMC—kidney cancer	3.19e-06	0.00033	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF2—kidney cancer	3.18e-06	0.000329	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	3.16e-06	0.000327	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—BRAF—kidney cancer	3.15e-06	0.000326	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—BCHE—kidney cancer	3.14e-06	0.000325	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PSMD7—kidney cancer	3.12e-06	0.000324	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF1R—kidney cancer	3.11e-06	0.000322	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—SLC5A5—kidney cancer	3.11e-06	0.000322	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF1R—kidney cancer	3.1e-06	0.000321	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CA9—kidney cancer	3.08e-06	0.000319	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF1R—kidney cancer	3.07e-06	0.000318	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—MAPK3—kidney cancer	3.07e-06	0.000318	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—POMC—kidney cancer	3.05e-06	0.000316	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—MAPK1—kidney cancer	3.05e-06	0.000316	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—BRAF—kidney cancer	3.01e-06	0.000312	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—SLC2A1—kidney cancer	3e-06	0.000311	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—RAF1—kidney cancer	3e-06	0.00031	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—RAF1—kidney cancer	2.99e-06	0.000309	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—BCHE—kidney cancer	2.96e-06	0.000307	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—IL2—kidney cancer	2.96e-06	0.000306	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—RAF1—kidney cancer	2.96e-06	0.000306	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—IL2—kidney cancer	2.95e-06	0.000305	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—SLC5A5—kidney cancer	2.93e-06	0.000303	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—IL2—kidney cancer	2.92e-06	0.000303	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—MAPK1—kidney cancer	2.92e-06	0.000302	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—PIK3CA—kidney cancer	2.91e-06	0.000302	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—KRAS—kidney cancer	2.88e-06	0.000298	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.86e-06	0.000296	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—SLC2A1—kidney cancer	2.83e-06	0.000293	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—PIK3CA—kidney cancer	2.79e-06	0.000289	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—KRAS—kidney cancer	2.76e-06	0.000286	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL2—kidney cancer	2.69e-06	0.000278	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL2—kidney cancer	2.68e-06	0.000277	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL2—kidney cancer	2.65e-06	0.000275	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—PIK3CA—kidney cancer	2.65e-06	0.000274	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—RAF1—kidney cancer	2.63e-06	0.000272	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CRABP1—kidney cancer	2.62e-06	0.000272	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—RELA—kidney cancer	2.61e-06	0.000271	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ERBB2—kidney cancer	2.6e-06	0.000269	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MTOR—kidney cancer	2.56e-06	0.000265	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HIF1A—kidney cancer	2.56e-06	0.000265	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—POMC—kidney cancer	2.56e-06	0.000265	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TSC2—kidney cancer	2.55e-06	0.000265	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HIF1A—kidney cancer	2.55e-06	0.000264	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TSC2—kidney cancer	2.55e-06	0.000264	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—PIK3CA—kidney cancer	2.53e-06	0.000262	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HIF1A—kidney cancer	2.53e-06	0.000262	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TSC2—kidney cancer	2.52e-06	0.000261	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—RAF1—kidney cancer	2.52e-06	0.00026	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—RELA—kidney cancer	2.5e-06	0.000259	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTP1—kidney cancer	2.5e-06	0.000259	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ERBB2—kidney cancer	2.49e-06	0.000258	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MTOR—kidney cancer	2.46e-06	0.000254	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—KDR—kidney cancer	2.45e-06	0.000254	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—KDR—kidney cancer	2.44e-06	0.000253	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ITPR2—kidney cancer	2.44e-06	0.000252	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—KDR—kidney cancer	2.42e-06	0.00025	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CDKN1B—kidney cancer	2.41e-06	0.000249	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTP1—kidney cancer	2.36e-06	0.000244	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL2—kidney cancer	2.35e-06	0.000244	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CDKN1B—kidney cancer	2.3e-06	0.000239	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTM1—kidney cancer	2.3e-06	0.000238	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCND1—kidney cancer	2.3e-06	0.000238	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—JUN—kidney cancer	2.29e-06	0.000237	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CTNNB1—kidney cancer	2.27e-06	0.000235	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APC—kidney cancer	2.26e-06	0.000234	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—KIT—kidney cancer	2.26e-06	0.000234	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL2—kidney cancer	2.26e-06	0.000233	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—KIT—kidney cancer	2.25e-06	0.000233	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APC—kidney cancer	2.25e-06	0.000233	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ABCB1—kidney cancer	2.23e-06	0.000231	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—KIT—kidney cancer	2.23e-06	0.000231	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APC—kidney cancer	2.23e-06	0.000231	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTT1—kidney cancer	2.22e-06	0.00023	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ACHE—kidney cancer	2.22e-06	0.00023	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PTEN—kidney cancer	2.22e-06	0.000229	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCND1—kidney cancer	2.2e-06	0.000228	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—JUN—kidney cancer	2.19e-06	0.000227	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP1A1—kidney cancer	2.18e-06	0.000226	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CTNNB1—kidney cancer	2.18e-06	0.000225	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTM1—kidney cancer	2.17e-06	0.000224	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—MAPK3—kidney cancer	2.16e-06	0.000224	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—MAPK3—kidney cancer	2.15e-06	0.000223	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—POMC—kidney cancer	2.15e-06	0.000222	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—POMC—kidney cancer	2.14e-06	0.000222	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	2.13e-06	0.000221	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PTEN—kidney cancer	2.12e-06	0.00022	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—BRAF—kidney cancer	2.12e-06	0.00022	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—POMC—kidney cancer	2.12e-06	0.00022	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—BRAF—kidney cancer	2.11e-06	0.000219	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SCARB1—kidney cancer	2.1e-06	0.000218	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—BRAF—kidney cancer	2.09e-06	0.000217	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS1—kidney cancer	2.08e-06	0.000216	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—MAPK1—kidney cancer	2.06e-06	0.000213	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.05e-06	0.000213	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—MAPK1—kidney cancer	2.05e-06	0.000212	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PSMD7—kidney cancer	2.04e-06	0.000212	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGS2—kidney cancer	2.04e-06	0.000211	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	2.03e-06	0.00021	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—VEGFA—kidney cancer	2e-06	0.000207	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—PIK3CA—kidney cancer	1.96e-06	0.000203	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—PIK3CA—kidney cancer	1.96e-06	0.000203	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—KRAS—kidney cancer	1.94e-06	0.000201	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	1.94e-06	0.000201	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—BCHE—kidney cancer	1.94e-06	0.000201	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—KRAS—kidney cancer	1.94e-06	0.0002	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—KRAS—kidney cancer	1.92e-06	0.000198	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—VEGFA—kidney cancer	1.92e-06	0.000198	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.91e-06	0.000198	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MAPK3—kidney cancer	1.89e-06	0.000196	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.85e-06	0.000191	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MYC—kidney cancer	1.84e-06	0.000191	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MAPK3—kidney cancer	1.81e-06	0.000188	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MAPK1—kidney cancer	1.8e-06	0.000187	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	1.78e-06	0.000185	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTEN—kidney cancer	1.78e-06	0.000184	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	1.78e-06	0.000184	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RAF1—kidney cancer	1.77e-06	0.000183	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RAF1—kidney cancer	1.77e-06	0.000183	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MYC—kidney cancer	1.76e-06	0.000183	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RELA—kidney cancer	1.76e-06	0.000183	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	1.76e-06	0.000182	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RELA—kidney cancer	1.76e-06	0.000182	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ERBB2—kidney cancer	1.75e-06	0.000181	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RAF1—kidney cancer	1.75e-06	0.000181	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ERBB2—kidney cancer	1.75e-06	0.000181	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RELA—kidney cancer	1.74e-06	0.00018	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ERBB2—kidney cancer	1.73e-06	0.000179	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MTOR—kidney cancer	1.73e-06	0.000179	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MAPK1—kidney cancer	1.73e-06	0.000179	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MTOR—kidney cancer	1.72e-06	0.000178	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MTOR—kidney cancer	1.71e-06	0.000177	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—KRAS—kidney cancer	1.7e-06	0.000176	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—KRAS—kidney cancer	1.63e-06	0.000169	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—POMC—kidney cancer	1.62e-06	0.000168	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	1.62e-06	0.000168	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	1.62e-06	0.000167	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	1.6e-06	0.000166	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL2—kidney cancer	1.59e-06	0.000164	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL2—kidney cancer	1.58e-06	0.000164	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL2—kidney cancer	1.57e-06	0.000162	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PIK3CA—kidney cancer	1.56e-06	0.000162	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCND1—kidney cancer	1.55e-06	0.00016	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—JUN—kidney cancer	1.54e-06	0.00016	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCND1—kidney cancer	1.54e-06	0.00016	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTP1—kidney cancer	1.54e-06	0.00016	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—JUN—kidney cancer	1.54e-06	0.000159	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	1.53e-06	0.000159	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—POMC—kidney cancer	1.53e-06	0.000159	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCND1—kidney cancer	1.53e-06	0.000158	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	1.53e-06	0.000158	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—JUN—kidney cancer	1.52e-06	0.000158	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	1.51e-06	0.000157	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TP53—kidney cancer	1.51e-06	0.000157	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	1.5e-06	0.000155	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PTEN—kidney cancer	1.49e-06	0.000155	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PTEN—kidney cancer	1.49e-06	0.000154	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PTEN—kidney cancer	1.47e-06	0.000153	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ABCB1—kidney cancer	1.46e-06	0.000151	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TP53—kidney cancer	1.45e-06	0.00015	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTM1—kidney cancer	1.42e-06	0.000147	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—VEGFA—kidney cancer	1.35e-06	0.00014	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—VEGFA—kidney cancer	1.35e-06	0.000139	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.34e-06	0.000139	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	1.33e-06	0.000138	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS2—kidney cancer	1.3e-06	0.000134	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MAPK3—kidney cancer	1.28e-06	0.000132	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MAPK3—kidney cancer	1.27e-06	0.000132	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	1.26e-06	0.00013	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PIK3CA—kidney cancer	1.26e-06	0.00013	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MYC—kidney cancer	1.24e-06	0.000129	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MYC—kidney cancer	1.24e-06	0.000128	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MYC—kidney cancer	1.23e-06	0.000127	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS2—kidney cancer	1.22e-06	0.000126	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MAPK1—kidney cancer	1.21e-06	0.000126	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MAPK1—kidney cancer	1.21e-06	0.000125	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	1.2e-06	0.000124	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—KRAS—kidney cancer	1.15e-06	0.000119	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—KRAS—kidney cancer	1.14e-06	0.000118	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—KRAS—kidney cancer	1.13e-06	0.000117	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTEN—kidney cancer	1.13e-06	0.000117	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTEN—kidney cancer	1.06e-06	0.00011	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	1.05e-06	0.000109	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	1.05e-06	0.000109	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	1.04e-06	0.000108	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TP53—kidney cancer	1.02e-06	0.000106	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TP53—kidney cancer	1.02e-06	0.000105	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TP53—kidney cancer	1.01e-06	0.000104	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—POMC—kidney cancer	1e-06	0.000104	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS2—kidney cancer	7.98e-07	8.27e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PIK3CA—kidney cancer	7.97e-07	8.25e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PIK3CA—kidney cancer	7.51e-07	7.78e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTEN—kidney cancer	6.96e-07	7.21e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.91e-07	5.09e-05	CbGpPWpGaD
